Company profile · Sponsor
Dermata
Dermata Therapeutics
- Pipeline
- 4
- Drugs
- 0
- Patents
- 8
Quick answer
Dermata (DRMA) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..
Company facts
Pipeline (4)
Search pipeline →Patents (8)
Search patents →-
US 12208123
Compositions and methods for the treatment of skin conditions
granted -
US 6759396
Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid
expired -
US 6593359
Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis
expired -
US 6515021
Bicyclic aromatic compounds
expired -
US 6506796
Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis
expired -
US 6368608
Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
expired -
US 6326510
Bi-aromatic compounds, compositions containing them and uses
expired -
US 6313162
Propynyl or dienyl biaromatic compounds
expired
Frequently asked questions
What is Dermata?
Dermata (DRMA) is a pharma company. headquartered in SAN DIEGO, CA, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 8 patents to this profile..
What pipeline programs does Dermata sponsor?
We track 4 ClinicalTrials.gov-linked programs for Dermata, including DMT310 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Dermata company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.